255 related articles for article (PubMed ID: 36256604)
1. Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer's related amyloid-beta pathology.
Su S; Esparza TJ; Brody DL
PLoS One; 2022; 17(10):e0276107. PubMed ID: 36256604
[TBL] [Abstract][Full Text] [Related]
2. VHHs as tools for therapeutic protein delivery to the central nervous system.
Wouters Y; Jaspers T; Rué L; Serneels L; De Strooper B; Dewilde M
Fluids Barriers CNS; 2022 Oct; 19(1):79. PubMed ID: 36192747
[TBL] [Abstract][Full Text] [Related]
3. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L
Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433
[TBL] [Abstract][Full Text] [Related]
4. Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobody.
Esparza TJ; Su S; Francescutti CM; Rodionova E; Kim JH; Brody DL
Fluids Barriers CNS; 2023 Aug; 20(1):64. PubMed ID: 37620930
[TBL] [Abstract][Full Text] [Related]
5. Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo.
Dorresteijn B; Rotman M; Faber D; Schravesande R; Suidgeest E; van der Weerd L; van der Maarel SM; Verrips CT; El Khattabi M
FEBS J; 2015 Sep; 282(18):3618-31. PubMed ID: 26147692
[TBL] [Abstract][Full Text] [Related]
6. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.
Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L
J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771
[TBL] [Abstract][Full Text] [Related]
7. Identification and in vivo characterization of a brain-penetrating nanobody.
Wouters Y; Jaspers T; De Strooper B; Dewilde M
Fluids Barriers CNS; 2020 Oct; 17(1):62. PubMed ID: 33054787
[TBL] [Abstract][Full Text] [Related]
8. Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease.
Chang R; Knox J; Chang J; Derbedrossian A; Vasilevko V; Cribbs D; Boado RJ; Pardridge WM; Sumbria RK
Mol Pharm; 2017 Jul; 14(7):2340-2349. PubMed ID: 28514851
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
10. Enhanced
Esparza TJ; Su S; Francescutti CM; Rodionova E; Kim JH; Brody DL
bioRxiv; 2023 Apr; ():. PubMed ID: 37333358
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.
Rofo F; Metzendorf NG; Saubi C; Suominen L; Godec A; Sehlin D; Syvänen S; Hultqvist G
Alzheimers Res Ther; 2022 Dec; 14(1):180. PubMed ID: 36471433
[TBL] [Abstract][Full Text] [Related]
12. High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain.
Fang XT; Hultqvist G; Meier SR; Antoni G; Sehlin D; Syvänen S
Neuroimage; 2019 Jan; 184():881-888. PubMed ID: 30300753
[TBL] [Abstract][Full Text] [Related]
13. Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets.
Li T; Vandesquille M; Koukouli F; Dudeffant C; Youssef I; Lenormand P; Ganneau C; Maskos U; Czech C; Grueninger F; Duyckaerts C; Dhenain M; Bay S; Delatour B; Lafaye P
J Control Release; 2016 Dec; 243():1-10. PubMed ID: 27671875
[TBL] [Abstract][Full Text] [Related]
14. Passive and receptor mediated brain delivery of an anti-GFAP nanobody.
Meier SR; Sehlin D; Syvänen S
Nucl Med Biol; 2022; 114-115():121-127. PubMed ID: 35487832
[TBL] [Abstract][Full Text] [Related]
15. Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-Aβ-Affibodies.
Faresjö R; Lindberg H; Ståhl S; Löfblom J; Syvänen S; Sehlin D
Pharm Res; 2022 Jul; 39(7):1509-1521. PubMed ID: 35538266
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease.
Gustavsson T; Metzendorf NG; Wik E; Roshanbin S; Julku U; Chourlia A; Nilsson P; Andersson KG; Laudon H; Hultqvist G; Syvänen S; Sehlin D
Alzheimers Res Ther; 2023 May; 15(1):90. PubMed ID: 37131196
[TBL] [Abstract][Full Text] [Related]
17. Receptor-mediated abeta amyloid antibody targeting to Alzheimer's disease mouse brain.
Zhou QH; Fu A; Boado RJ; Hui EK; Lu JZ; Pardridge WM
Mol Pharm; 2011 Feb; 8(1):280-5. PubMed ID: 21141969
[TBL] [Abstract][Full Text] [Related]
18. Disaggregation of amyloid plaque in brain of Alzheimer's disease transgenic mice with daily subcutaneous administration of a tetravalent bispecific antibody that targets the transferrin receptor and the Abeta amyloid peptide.
Sumbria RK; Hui EK; Lu JZ; Boado RJ; Pardridge WM
Mol Pharm; 2013 Sep; 10(9):3507-13. PubMed ID: 23924247
[TBL] [Abstract][Full Text] [Related]
19. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease.
Jordão JF; Ayala-Grosso CA; Markham K; Huang Y; Chopra R; McLaurin J; Hynynen K; Aubert I
PLoS One; 2010 May; 5(5):e10549. PubMed ID: 20485502
[TBL] [Abstract][Full Text] [Related]
20. Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease.
Nasr SH; Kouyoumdjian H; Mallett C; Ramadan S; Zhu DC; Shapiro EM; Huang X
Small; 2018 Jan; 14(3):. PubMed ID: 29134771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
